Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
As of close of business last night, Rani Therapeutics Holdings Inc’s stock clocked out at $0.54, down -2.05% from its previous closing price of $0.55. In other words, the price has decreased by -$2.05 from its previous closing price. On the day, 0.57 million shares were traded. RANI stock price reached its highest trading level at $0.55 during the session, while it also had its lowest trading level at $0.52.
Ratios:
To gain a deeper understanding of RANI’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.88 and its Current Ratio is at 0.88.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Oppenheimer on August 02, 2024, initiated with a Outperform rating and assigned the stock a target price of $17.
On June 14, 2024, Maxim Group started tracking the stock assigning a Buy rating and target price of $15.
On June 13, 2024, Rodman & Renshaw started tracking the stock assigning a Buy rating and target price of $10.Rodman & Renshaw initiated its Buy rating on June 13, 2024, with a $10 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Dec 13 ’24 when McKinley Kate bought 17,960 shares for $1.67 per share. The transaction valued at 29,993 led to the insider holds 17,960 shares of the business.
Imran Talat bought 10,296 shares of RANI for $19,974 on Dec 09 ’24. The Chief Executive Officer now owns 494,751 shares after completing the transaction at $1.94 per share. On Oct 15 ’24, another insider, South Cone Investments Limited, who serves as the 10% Owner of the company, sold 3,829,360 shares for $2.65 each. As a result, the insider received 10,141,674 and left with 8,302,194 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, RANI now has a Market Capitalization of 36882404 and an Enterprise Value of 25513298. For the stock, the TTM Price-to-Sale (P/S) ratio is 30.17. Its current Enterprise Value per Revenue stands at 21.261 whereas that against EBITDA is -0.548.
Stock Price History:
The Beta on a monthly basis for RANI is -0.01, which has changed by -0.79925096 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, RANI has reached a high of $3.75, while it has fallen to a 52-week low of $0.39. The 50-Day Moving Average of the stock is -2.09%, while the 200-Day Moving Average is calculated to be -59.88%.
Shares Statistics:
It appears that RANI traded 1.90M shares on average per day over the past three months and 1343660 shares per day over the past ten days. A total of 33.57M shares are outstanding, with a floating share count of 31.01M. Insiders hold about 28.86% of the company’s shares, while institutions hold 5.78% stake in the company. Shares short for RANI as of 1752537600 were 7128214 with a Short Ratio of 3.74, compared to 1749772800 on 3634461. Therefore, it implies a Short% of Shares Outstanding of 7128214 and a Short% of Float of 23.919999999999998.
